Skip to main content

Differentiation Therapy of Acute Promyelocytic Leukemia

  • Conference paper
Tumor Biology

Part of the book series: NATO ASI Series ((ASIH,volume 99))

  • 148 Accesses

Abstract

Abnormal are the malignant cells. The genome is abnormal including chromosomal translocations, gene deletions or mutations. Malignant cell seems to be in an irreversible state. Therefore the only way to treat a patient with cancer is to eliminate the tumor by surgery, radiotherapy, chemotherapy and more recently immunotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Borrow J., Goddard A.D., Sheer D. and Solomon E. (1990) Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science, 249: 1577–1580.

    Article  PubMed  CAS  Google Scholar 

  • Castaigne S., Chomienne C., Daniel MT, Ballerini P., Berger R., Fenaux P., Degos L. (1990) All trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood, 76: 1704–1709.

    PubMed  CAS  Google Scholar 

  • Castaigne S., Lefebvre P., Chomienne C., Sue E., Rigal-Huguet F., Gardin C., Delmer A., Archimbaud E., Tilly H., Janvier M., Isnard F., Travade P., Montfort L., Delannoy A., Rapp MH., Christian G., Montastruc M., Weh H., Fenaux P., Dombret H., Gourmel B. and Degos L. (1993) Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute preomyelocytic leukemia. Blood, 82: 3560–3563.

    PubMed  CAS  Google Scholar 

  • Castaigne S., Balitrand N., de The H., Dejean A., Degos L. and Chomienne C. (1992) A PML/RAR alpha fusion transcript is constantly detected by RNA based polymerase chain reaction in acute promyelocytic leukemia. Blood, 79: 3110–3115.

    PubMed  CAS  Google Scholar 

  • Chomienne C., Ballerini P., Balitrand N., Daniel MT., Fenaux P., Castaigne S., Degos L. (1990) All trans retinoic acid in acute promyelocytic leukemia. II. In vitro studies: structure function relationship. Blood, 76: 1710–1717.

    PubMed  CAS  Google Scholar 

  • Chomienne C., Ballerini P., Balitrand N., Huang ME., Krawice I., Castaigne S., Fenaux P., Tiollais P., Dejean A., Degos L., de The H. (1990) The retinoic acid receptor alpha gene is rearranged in retinoic acid sensitive promyelocytic leukemia. Leukemia, 4: 802–807.

    PubMed  CAS  Google Scholar 

  • Chomienne C., Balitrand N., Ballerini P., Castaigne S., de The H., Degos L. (1991) All trans retinoic acid modulates the retinoic receptor alpha in promyelocytic cells. J. Clin. Invest., 88: 2150–2154.

    Article  PubMed  CAS  Google Scholar 

  • Cornic M., Delva L., Guidez F., Balitrand N., Degos L., Chomienne C. (1992) Induction of retinoic acid binding protein in normal and malignant human myeloid cells by retinoic acid in AML3 patients. Cancer Res., 52: 3329–3334.

    PubMed  CAS  Google Scholar 

  • Daniel MT., Kiken M., Romagne O., Barbey S., Bazarbachi A., Stadler M., Guillemin M.C., Degos L., Chomienne C., de The H. (1993) PML protein expression in haematopoietic and APL cells. Blood, 82: 1858–1867.

    PubMed  CAS  Google Scholar 

  • Degos L., Chomienne C., Daniel MT., Berger R., Dombret H., Fenaux P., Castaigne S. (1990) Treatment of frist relapse in acute promyelocytic leukemia with all trans retinoic acid. Lancet, 2: 1440.

    Article  Google Scholar 

  • de The H., Chomienne C., Lanotte M., Degos L., Dejean A. (1990) The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature, 347: 558–561.

    Article  PubMed  Google Scholar 

  • de The H., Lavau C., Marchio A., Chomienne C., Degos L., Dejean A. (1991) The PML-RAR fusion mRNA generated by the t(15;17) trans location in acute promyelocytic leukemia encodes a functionnally altered RAR. Cell, 66: 675–684.

    Article  PubMed  Google Scholar 

  • Dombret H., Sutton L., Duarte M., Daniel MT., Leblond V., Castaigne S., Degos L. (1992) Combinet therapy with all-trans retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage. Leukemia, 6: 1237–1242.

    PubMed  CAS  Google Scholar 

  • Fenaux P., Castaigne S., Dombret H., Chomienne C., Duarte M., Archimbaud E., Lamy T., Tibeghien P., Tilly H., Dufour P., Cransac M., Guerci A., Sadoun A. and Degos L. (1991) All-trans retinoic acid in newly diagnosed acute promyelocytic leukemia: a pilot study. Blood (ASH Abstract n° 305 — plenary session) p 79a.

    Google Scholar 

  • Fenaux P., Castaigne S., Dombret H., Archimbaud E., Duarte M., Morel P., Lamy T., Tilly H., Guerci A., Maloisel F., Bordessoule D., Sadoun A., Tiberghien P., Fegueux N., Daniel MT., Chomienne C., Degos L. (1992) All-trans retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases. Blood, 80: 2176–2181.

    PubMed  CAS  Google Scholar 

  • Fenaux P., Le Deley MC., Castaigne S. et al (1993) Effect of all trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. Blood, 82: 3241–3249.

    PubMed  CAS  Google Scholar 

  • Frankel SR., Eardley A., Lauwers G., Weiss M. and Warrel RP (1992) The “retinoic acid syndrome” in acute promyelocytic leukemia. Ann. Intern. Med, 117: 292–296.

    PubMed  CAS  Google Scholar 

  • Housset M., Daniel MT, Degos L. (1982) Small doses of ARA-C in the treatment of acute myeloid leukemia: differentiation of myeloid leukemia cells ? Brit. J. Haematol. 51: 125–129.

    Article  CAS  Google Scholar 

  • Huang M., Yu-Chen Y., Shu-Rong C., Lu MX., Zhoa L., Gu LJ., Wang ZY (1988) Use of all trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 73: 567.

    Google Scholar 

  • Kakizuka A., Miller WH., Umesono K. et al (1991) Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell, 66: 663–674.

    Article  PubMed  CAS  Google Scholar 

  • Muindi JF., Young CW (1993) Lipid hydroperoxides greatly increase the rate of oxidative catabolism of all trans retinoic acid by human cell culture microsomes genetically enriched in specified cytochrome p-450 isoforms. Cancer Res, 53: 1226–1229.

    PubMed  CAS  Google Scholar 

  • Pandolfi PP, Grignani F., Alcalay M. et al (1991) Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene, 6: 1285–1292.

    PubMed  CAS  Google Scholar 

  • Rousselot P., Hardas B., Patel A., Guidez F., Gaken J., Castaigne S., Dejean A., de The H., Degos L., Farzaneh F., Chomienne C. (1994) The PML/RAR alpha gene product of the t(15; 17) translocation inhibits retinoic acid induced differentiation and mediated transactivation in human myeloid cells. Oncogene, 9: 545–551.

    PubMed  CAS  Google Scholar 

  • Rowley JD., Golomb HM., Gougherty C., (1977) 15/17 translocation: a consistent chromosomal change in acute promyelocytic leukaemia. Lancet, 1: 549–550.

    Article  PubMed  CAS  Google Scholar 

  • Sachs L. (1978) Control of normal differentiation and the phenotypic reversion of malignancy in myeloid leukemia cells. Nature, 274: 535.

    Article  PubMed  CAS  Google Scholar 

  • Tilly H., Castaigne S., Bordessoule D., Casassus P., Le Prise P., Tertian G., Desablens B., Henry-Amar M., Degos L. (1990) Low dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly. J. Clin. Oncol., 8: 272–279.

    PubMed  CAS  Google Scholar 

  • Wang ZY, Degos L. (1993) Retinoic acid in hematological malignancies. International Symposium, Shanghai, Chine 19–21 octobre 1993.

    Google Scholar 

  • Warrell RP., Muindi J., Frankel SR., Jakubowski A., Dmitrovsky E., Miller WH. (1991) Continuous treatment with all trans retinoic acid progressively decreases plasma drug concentrations: implications for relapse and resistance in acute promyelocytic leukemia. Blood (ASH abstract n° 1063, p. 268a.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Degos, L. (1996). Differentiation Therapy of Acute Promyelocytic Leukemia. In: Tsiftsoglou, A.S., Sartorelli, A.C., Housman, D.E., Dexter, T.M. (eds) Tumor Biology. NATO ASI Series, vol 99. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-61180-3_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-61180-3_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64735-2

  • Online ISBN: 978-3-642-61180-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics